BMRN vs ENVX · P/E 40, rev $1.76B vs rev $16.6M
Biomarin Pharmaceutical Inc (BMRN) versus Enovix Corp (ENVX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Enovix Corp (ENVX) is a electrical equipment & parts company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported ENVX revenue for 2026-07-05 was $16.6M. Net income was -$81.3M. ENVX currently screens at market cap $2.79B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. ENVX currently screens at market cap $2.79B.
Not investment advice. Open the BMRN and ENVX stock pages for the full models.
Not investment advice.